SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601830-24-000094
Filing Date
2024-06-27
Accepted
2024-06-27 19:13:26
Documents
1
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1719529999.html 4  
1 FORM 4 wk-form4_1719529999.xml 4 3706
  Complete submission text file 0001601830-24-000094.txt   5297
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Borgeson Blake (Reporting) CIK: 0001856094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 241080934